Baylor research spearheaded major changes in guidelines
In February 2022, the American College of Gastroenterology (ACG) released an updated set of guidelines for the diagnosis and management of GERD, the latest update in nearly a decade. Research from Baylor University Medical Center at Dallas helped shape these new practice guidelines. Stuart Spechler, MD, chief of the division of gastroenterology at Baylor Dallas and senior author on the guidelines manuscript says, "One of the major changes to the guidelines came from work done here at Baylor Dallas. We were the first to point out that if patients are taking proton pump inhibitors (PPIs) at the time of endoscopy, the PPIs can mask the presence of eosinophilic esophagitis, an allergic disorder of the esophagus that can be confused with GERD. So, for patients who have not responded well to PPIs, it is now recommended to stop the PPIs for two weeks before diagnostic endoscopy. This was not a common clinical practice prior to the publication of our findings, and it is now standard clinical practice around the world."
Rhonda Souza, MD, co-director of the Center for Esophageal Research Disease at Baylor Scott & White Research Institute was also co-author to new guidelines for the diagnosis, surveillance and treatment of Barrett’s esophagus published by the American College of Gastroenterology.